REGN FY2025 SEC EDGAR DEF 14A #84 of 168 in industry

Regeneron Pharmaceuticals, Inc. CEO pay ratio

The CEO earned $7.3M in FY2025 against median worker pay of $174,138 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
NY
Filing date
2026-04-24
Industry
Chemicals & Pharmaceuticals
Industry rank
#84/168

Data updated August 2026

Subscribe to Regeneron Pharmaceuticals, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
42:1
Below Average (Scale: 0–1000:1)
CEO pay
$7.3M
Median worker
$174,138

Answer first

Regeneron Pharmaceuticals, Inc.'s FY2025 CEO total of $7.3M ranks #743 of 1,423 complete filings; its 42:1 pay ratio ranks #1048. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $174,138. Industry placement uses the FY2025 SIC-28 peer cohort (# 84 of 168, 51st percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#743
$7.3M of 1,423 FY2025
Ratio rank
#1048
42:1 of 1,423
Industry pct
51st
above the industry median pay ratio

How Regeneron Pharmaceuticals, Inc. ranks nationally

Regeneron Pharmaceuticals, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$7,313,796 48th percentile higher than 48% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Regeneron Pharmaceuticals, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($7.3M) against pay ratio (42:1) for Regeneron Pharmaceuticals, Inc. (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both03398027.16796054.210194081.313592108.440.9:141.7:142.5:143.3:144.1:1CEO total payPay ratio (CEO : median worker)Regeneron Pharmaceuticals, Inc., CEO total pay: 7313796 · Pay ratio (CEO : median worker): 42:1Regeneron Pharmaceuticals, Inc.Opko Health, Inc., CEO total pay: 1854000 · Pay ratio (CEO : median worker): 42:1Opko Health, Inc.Emergent BioSolutions Inc., CEO total pay: 130553 · Pay ratio (CEO : median worker): 41:1Emergent BioSolutions Inc.Biocryst Pharmaceuticals Inc, CEO total pay: 12951082 · Pay ratio (CEO : median worker): 41:1Biocryst Pharmaceuticals IncOlaplex Holdings, Inc., CEO total pay: 149243 · Pay ratio (CEO : median worker): 44:1Olaplex Holdings, Inc.
Regeneron Pharmaceuticals, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Regeneron Pharmaceuticals, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Regeneron Pharmaceuticals, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
42:1
FY2025
vs prior FY
-158:1
from FY2024 200:1
CEO $ YoY
-78%
$7.3M latest
Filings shown
5
FY2021–2025
Regeneron Pharmaceuticals, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $32.5M - $149,250 218:1 -
2022 $33.1M +1.6% $162,115 204:1 -14:1
2023 $34.2M +3.3% $165,843 206:1 +2:1
2024 $32.9M -3.7% $164,447 200:1 -6:1
2025 $7.3M -78% $174,138 42:1 -158:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 872589, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
42:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$7.3M
Companies in Industry
168
vs. Industry Median
Below
#84 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Regeneron Pharmaceuticals, Inc.: MODEST · HEAVY pay ratio

Regeneron Pharmaceuticals, Inc.'s 42:1 ratio ranks #1048 of 1,423 FY2025 complete filings (lower third by ratio). the CEO earned 42× the median employee ($174,138) in FY2025.

Median employee $174,138 (ELITE-MED); MODEST · HEAVY stamps put about 42 median-wage years per CEO year.

CEO Total Pay

$7.3M

FY2025 Summary Compensation, near median

Pay Ratio

42:1

Below typical

Regeneron Pharmaceuticals, Inc. in the lower-ratio third

Regeneron Pharmaceuticals, Inc.'s 42:1 ratio ranks #1048 of 1,423 FY2025 complete filings (lower third by ratio). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Regeneron Pharmaceuticals, Inc.'s $7.3M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #743 and ratio rank #1048 split - treat 42:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$7.3M
Median Employee Pay
$174,138
Pay Ratio
42:1
Filing Date
2026-04-24

Company Info

Ticker
REGN
CIK
872589
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
NY
View SEC filings →
SEC EDGAR DEF 14A for CIK 872589, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Regeneron Pharmaceuticals, Inc.'s 42:1 ratio ranks #1048 of 1,423 FY2025 complete filings (lower third by ratio).

Read with Regeneron Pharmaceuticals, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · HEAVY · ELITE-MED.

Orthofix Medical Inc. · HEAVY

ABS(ceo_total_comp) peer at $7.3M (Δ $6K heavier vs Regeneron Pharmaceuticals, Inc.); MID · HIGH-MED vs this page's MODEST · HEAVY · ELITE-MED.
Terex Corp · HEAVY

ABS(ceo_total_comp) peer at $7.3M (Δ $28K lighter vs Regeneron Pharmaceuticals, Inc.); MID · PAR-MED vs this page's MODEST · HEAVY · ELITE-MED.
Syndax Pharmaceuticals Inc · HEAVY

ABS(ceo_total_comp) peer at $7.3M (Δ $32K lighter vs Regeneron Pharmaceuticals, Inc.); FLOOR · ELITE-MED vs this page's MODEST · HEAVY · ELITE-MED.
Schneider National, Inc. · HEAVY

ABS(ceo_total_comp) peer at $7.4M (Δ $38K heavier vs Regeneron Pharmaceuticals, Inc.); MID · PAR-MED vs this page's MODEST · HEAVY · ELITE-MED.
Opko Health, Inc. (SIC 28 pole)

Opko Health, Inc. stamps MODEST · LIGHT nearest in-SIC by ABS(pay_ratio) to Regeneron Pharmaceuticals, Inc.'s MODEST filing.
National dual ranks · #743/#1048

Regeneron Pharmaceuticals, Inc.'s FY2025 package sits #743 by CEO dollars and #1048 by ratio under HEAVY · MODEST.
Ratio primer · MODEST

Regeneron Pharmaceuticals, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Regeneron Pharmaceuticals, Inc. (CIK 872589), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.